APCER Pharma’s revenues grew by a lot more than 40 percent in 2013 APCER Pharma, the truly global service provider of strategic and outsourced providers for clinical safety, pharmacovigilance, medical affairs, and regulatory procedures, announced today that revenues grew by a lot more than 40 percent in 2013 when compared to previous year. The held company privately, which ended its fiscal year on March 31, gained eight new clients during the period and acts 5 of the very best 20 global pharmaceutical firms now Is acyclovir and valacyclovir the same thing? .
What this means is that treating prostate and breasts cancers require completely opposing approaches to AR. In treating prostate cancers, the strategy should be to block AR; in breasts cancer, the strategy ought to be to support AR production. Experts from Cleveland Clinic’s Lerner Analysis Institute, including Charis Eng, M.D., Ph.D., Chair, Genomic Medicine Institute; Robert Silverman, Ph.D., and Warren Heston, Ph.D., both of the Department of Cancer Biology; focused on if the androgen receptor molecule offers proof the tumor suppressor protein PTEN. The extensive research found that AR inhibits PTEN expression in prostate cancers cells, but stimulates it in breasts cancer cells.